ORGANIZATION OF MEASURES TO PREVENT ONCO-GYNECOLOGICAL DISEASES IN FAMILY POLYCLINICS

Rasulova N.; Navruzova V.

doi:10.5281/zenodo.12608985

ORGANIZATION OF MEASURES TO PREVENT ONCO-GYNECOLOGICAL DISEASES IN FAMILY POLYCLINICS

01.07.2024 International Scientific Journal "Science and Innovation". Series D. Volume 3 Issue 6

Rasulova N., Navruzova V.

Abstract. The prevention of onco-gynecological diseases within the framework of family polyclinics is essential for reducing the incidence and improving the early detection of these conditions among women. This article outlines a comprehensive approach to organizing preventive measures in family polyclinics, emphasizing the importance of regular screenings, patient education, and lifestyle interventions. By implementing systematic screening programs for cervical and breast cancer, offering educational sessions on risk factors and early signs, and promoting healthy lifestyle choices, family polyclinics can play a pivotal role in reducing the burden of onco-gynecological diseases. The integration of these preventive measures into routine primary care ensures that women receive continuous and accessible care, thereby enhancing the overall effectiveness of cancer prevention strategies.

Keywords: onco-gynecological diseases, Family polyclinics, Cancer prevention, Cervical cancer screening, Breast cancer screening, Patient education, Lifestyle interventions, Early detection, Women's health, Primary care integration.

References:

1. Arbyn, M., Smith, S. B., Temin, S., Sultana, F., Castle, P., Collaboration on Self-Sampling and HPV Testing. (2018). Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses. BMJ (Clinical research ed.), 363, k4823. 2. Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., ... & Kitchener, H. (2019). Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. The Lancet, 393(10167), 143-155. 3. Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y. C. T., ... & Wender, R. (2015). Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA, 314(15), 1599–1614. 4. Siu, A. L. (2016). Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 164(4), 279–296. 5. Woudstra, A. J., & Dekker, E. (2018). The effectiveness of using eHealth technologies to improve health and wellbeing in perimenopausal and postmenopausal women: Systematic review. Journal of Medical Internet Research, 20(5), e151. 6. von Wagner, C., Baio, G., Raine, R., Snowball, J., Morris, S., Atkin, W., ... & Wardle, J. (2011). Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. International Journal of Epidemiology, 40(3), 712–718. 7. Colditz, G. A., Wolin, K. Y., & Gehlert, S. (2012). Applying what we know to accelerate cancer prevention. Science Translational Medicine, 4(127), 127rv4–127rv4. 8. Chlebowski, R. T., Anderson, G. L., Manson, J. E., Pettinger, M., Yasmeen, S., Lane, D., ... & Wactawski-Wende, J. (2019). Estrogen alone and joint effects of randomized hormone therapy in women with prior hysterectomy. Journal of Clinical Oncology, 37(12), 944–955.